The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 11, 2017
Filed:
Mar. 15, 2014
Applicants:
Taiwan Liposome Company, Ltd, Taipei, TW;
Tlc Biopharmaceuticals, Inc., South San Francisco, CA (US);
Inventors:
Assignees:
TLC Biopharmaceuticals, Inc., South San Francisco, CA (US);
Taiwan Liposome Company, Ltd., Taipei, TW;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/127 (2006.01); A61K 31/337 (2006.01); A61K 31/4745 (2006.01); A61K 31/475 (2006.01); A61K 31/704 (2006.01); A61K 31/7048 (2006.01);
U.S. Cl.
CPC ...
A61K 9/127 (2013.01); A61K 31/337 (2013.01); A61K 31/475 (2013.01); A61K 31/4745 (2013.01); A61K 31/704 (2013.01); A61K 31/7048 (2013.01); Y10S 977/907 (2013.01);
Abstract
The present invention relates to a pharmaceutical composition comprising at least one liposome, at least one polyvalent counterion donor or a pharmaceutically acceptable salt thereof, at least one monovalent counterion donor or a pharmaceutically acceptable salt thereof, and an amphipathic therapeutic agent. The present invention also relates to methods of inhibiting cancer cell growth, comprising administering the pharmaceutical composition described herein.